Pioglitazone (AD-4833) ameliorates insulin resistance in patients with NIDDM. AD-4833 Glucose Clamp Study Group, Japan.
Yamasaki Y, Kawamori R, Wasada T, Sato A, Omori Y, Eguchi H, Tominaga M, Sasaki H, Ikeda M, Kubota M, Ishida Y, Hozumi T, Baba S, Uehara M, Shichiri M, Kaneko T.
Yamasaki Y, et al. Among authors: kubota m.
Tohoku J Exp Med. 1997 Nov;183(3):173-83. doi: 10.1620/tjem.183.173.
Tohoku J Exp Med. 1997.
PMID: 9550126
Free article.
Clinical Trial.